玻璃体混浊治疗的研究进展
Research Progress in the Treatment of Vitreous Opacity
DOI: 10.12677/acm.2026.1662234, PDF,    科研立项经费支持
作者: 黄琬窈, 李爽乐*:自贡市第一人民医院眼科,四川 自贡;雷中杰:自贡市第一人民医院泌尿外科,四川 自贡
关键词: 玻璃体混浊飞蚊症发病机制诊断治疗Vitreous Opacity Floaters Pathogenesis Diagnosis Treatment
摘要: 随着科学技术的不断发展,人们的生活水平不断提高,对视力的要求逐渐增加,生理性的玻璃体混浊引起的“飞蚊症”逐渐受到关注。患者对于清晰视力的迫切要求不断推进相关治疗手段的进步和革新。目前解决生理性玻璃体混浊的方式主要包括药物治疗、微创玻璃体切除手术治疗、YAG激光治疗、纳米气泡玻璃体消融术、超声波治疗、中医治疗、饮食治疗等。本文就玻璃体混浊的发病机制,诊断手段及治疗方式进行综述。
Abstract: With the continuous development of science and technology, people’s living standards are constantly improving. And the demand for vision is gradually increasing. Physiological vitreous opacity causing “floaters” is gradually receiving attention. The urgent demand of patients for clear vision is constantly advancing and innovating related treatment methods. At present, the main ways to solve physiological vitreous opacity include drug therapy, minimally invasive vitrectomy surgery, YAG laser therapy, nano bubble vitreous ablation, ultrasound therapy, traditional Chinese medicine therapy, dietary therapy, etc. This article reviews the pathogenesis, diagnostic methods, and treatment approaches of vitreous opacity.
文章引用:黄琬窈, 雷中杰, 李爽乐. 玻璃体混浊治疗的研究进展[J]. 临床医学进展, 2026, 16(6): 416-424. https://doi.org/10.12677/acm.2026.1662234

参考文献

[1] Katsanos, A., Tsaldari, N., Gorgoli, K., Lalos, F., Stefaniotou, M. and Asproudis, I. (2020) Safety and Efficacy of YAG Laser Vitreolysis for the Treatment of Vitreous Floaters: An Overview. Advances in Therapy, 37, 1319-1327. [Google Scholar] [CrossRef] [PubMed]
[2] Milston, R., Madigan, M.C. and Sebag, J. (2016) Vitreous Floaters: Etiology, Diagnostics, and Management. Survey of Ophthalmology, 61, 211-227. [Google Scholar] [CrossRef] [PubMed]
[3] Sebag, J. (2020) Vitreous and Vision Degrading Myodesopsia. Progress in Retinal and Eye Research, 79, Article 100847. [Google Scholar] [CrossRef] [PubMed]
[4] Shah, C.P. and Heier, J.S. (2017) YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial. JAMA Ophthalmology, 135, 918-923. [Google Scholar] [CrossRef] [PubMed]
[5] Bishop, P.N. (2000) Structural Macromolecules and Supramolecular Organisation of the Vitreous Gel. Progress in Retinal and Eye Research, 19, 323-344. [Google Scholar] [CrossRef] [PubMed]
[6] Phillips, J.D., Hwang, E.S., Morgan, D.J., Creveling, C.J. and Coats, B. (2022) Structure and Mechanics of the Vitreoretinal Interface. Journal of the Mechanical Behavior of Biomedical Materials, 134, Article 105399. [Google Scholar] [CrossRef] [PubMed]
[7] Ayalon, A., Sahel, J.A. and Chhablani, J. (2024) A Journey through the World of Vitreous. Survey of Ophthalmology, 69, 957-966. [Google Scholar] [CrossRef] [PubMed]
[8] Garcia, G.A., Khoshnevis, M., Yee, K.M.P., Nguyen-Cuu, J., Nguyen, J.H. and Sebag, J. (2016) Degradation of Contrast Sensitivity Function Following Posterior Vitreous Detachment. American Journal of Ophthalmology, 172, 7-12. [Google Scholar] [CrossRef] [PubMed]
[9] Senra, H., Ali, Z., Aslam, T. and Patton, N. (2024) Personality Traits and Symptoms of Anxiety and Depression in Patients with Primary Vitreous Floaters. Graefes Archive for Clinical and Experimental Ophthalmology, 262, 3153-3160. [Google Scholar] [CrossRef] [PubMed]
[10] Neudorfer, M., Fuhrer, A., Zur, D. and Barak, A. (2018) The Role of Posterior Vitreous Detachment on the Efficacy of Anti-Vascular Endothelial Growth Factor Intravitreal Injection for Treatment of Neovascular Age-Related Macular Degeneration. Indian Journal of Ophthalmology, 66, 1802-1807. [Google Scholar] [CrossRef] [PubMed]
[11] Ruminski, D., Sebag, J., Toledo, R.D., Jiménez-Villar, A., Nowak, J.K., Manzanera, S., et al. (2021) Volumetric Optical Imaging and Quantitative Analysis of Age-Related Changes in Anterior Human Vitreous. Investigative Opthalmology & Visual Science, 62, Article 31. [Google Scholar] [CrossRef] [PubMed]
[12] Mamou, J., Wa, C.A., Yee, K.M.P., Silverman, R.H., Ketterling, J.A., Sadun, A.A., et al. (2015) Ultrasound-Based Quantification of Vitreous Floaters Correlates with Contrast Sensitivity and Quality of Life. Investigative Ophthalmology & Visual Science, 56, 1611-1617. [Google Scholar] [CrossRef] [PubMed]
[13] Son, G., Sohn, J. and Kong, M. (2021) Acute Symptomatic Vitreous Floaters Assessed with Ultra-Wide Field Scanning Laser Ophthalmoscopy and Spectral Domain Optical Coherence Tomography. Scientific Reports, 11, Article No. 8930. [Google Scholar] [CrossRef] [PubMed]
[14] Garcia-Aguirre, G., Henaine-Berra, A. and Salcedo-Villanueva, G. (2022) Visualization and Grading of Vitreous Floaters Using Dynamic Ultra-Widefield Infrared Confocal Scanning Laser Ophthalmoscopy: A Pilot Study. Journal of Clinical Medicine, 11, Article 5502. [Google Scholar] [CrossRef] [PubMed]
[15] Mangione, C.M., Lee, P.P., Gutierrez, P.R., et al. (2001) Development of the 25-List-Item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology, 119, 1050-1058. [Google Scholar] [CrossRef] [PubMed]
[16] Kim, Y.K., Moon, S.Y., Yim, K.M., Seong, S.J., Hwang, J.Y. and Park, S.P. (2017) Psychological Distress in Patients with Symptomatic Vitreous Floaters. Journal of Ophthalmology, 2017, Article ID: 3191576. [Google Scholar] [CrossRef] [PubMed]
[17] Gouliopoulos, N., Oikonomou, D., Karygianni, F., Rouvas, A., Kympouropoulos, S. and Moschos, M.M. (2024) The Association of Symptomatic Vitreous Floaters with Depression and Anxiety. International Ophthalmology, 44, Article No. 218. [Google Scholar] [CrossRef] [PubMed]
[18] 韩菊. 氨碘肽注射液治疗玻璃体混浊疗效观察[J]. 中国现代药物应用, 2018, 12(18): 130-131.
[19] Aleman, A.I., Kiryakoza, L., Sridhar, J. and Sengillo, J. (2024) Management of Vitreous Floaters: A Review. Current Opinion in Ophthalmology, 35, 365-368. [Google Scholar] [CrossRef] [PubMed]
[20] García, B.G., Orduna Magán, C., Alvarez-Peregrina, C., Villa-Collar, C. and Sánchez-Tena, M.Á. (2021) Nd:YAG Laser Vitreolysis and Health-Related Quality of Life in Patients with Symptomatic Vitreous Floaters. European Journal of Ophthalmology, 32, 1143-1148. [Google Scholar] [CrossRef] [PubMed]
[21] Ankamah, E., Green-Gomez, M., Roche, W., Ng, E., Welge-Lüßen, U., Kaercher, T., et al. (2021) Dietary Intervention with a Targeted Micronutrient Formulation Reduces the Visual Discomfort Associated with Vitreous Degeneration. Translational Vision Science & Technology, 10, Article 19. [Google Scholar] [CrossRef] [PubMed]
[22] 刘贵江. 玻璃体混浊的治疗进展[J]. 医疗装备, 2021, 34(3): 193-194.
[23] 肖养奇, 谢翠娟. 卵磷脂络合碘胶囊与复方血栓通片在玻璃体混浊治疗中的疗效评价[J]. 吉林医学, 2019, 40(10): 2302-2304.
[24] 李桂芬, 史季桐, 费福建. 玻璃体消融术与玻璃体切除术治疗飞蚊症的临床对比研究[J]. 西南国防医药, 2017, 27(7): 688-691.
[25] Zeydanli, E.O., Parolini, B., Ozdek, S., Bopp, S., Adelman, R.A., Kuhn, F., et al. (2020) Management of Vitreous Floaters: An International Survey the European Vitreoretinal Society Floaters Study Report. Eye, 34, 825-834. [Google Scholar] [CrossRef] [PubMed]
[26] Dysager, D.D., Koren, S.F., Grauslund, J., Wied, J. and Subhi, Y. (2022) Efficacy and Safety of Pars Plana Vitrectomy for Primary Symptomatic Floaters: A Systematic Review with Meta-Analyses. Ophthalmology and Therapy, 11, 2225-2242. [Google Scholar] [CrossRef] [PubMed]
[27] Markatia, Z., Hudson, J., Leung, E.H., Sajjad, A. and Gibbons, A. (2022) The Postvitrectomy Cataract. International Ophthalmology Clinics, 62, 79-91. [Google Scholar] [CrossRef] [PubMed]
[28] Woudstra-de Jong, J.E., Manning-Charalampidou, S.S., Vingerling, H., Busschbach, J.J. and Pesudovs, K. (2023) Patient-Reported Outcomes in Patients with Vitreous Floaters: A Systematic Literature Review. Survey of Ophthalmology, 68, 875-888. [Google Scholar] [CrossRef] [PubMed]
[29] 畅立斌, 魏航, 许正杰, 等. 玻璃体激光消融术治疗飞蚊症的效果及相关因素分析[J]. 中国临床医生杂志, 2023, 51(5): 616-618.
[30] 冯文莉, 马伊, 景原媛. YAG激光玻璃体消融术对玻璃体混浊患者视觉相关生活质量和精神心理状态的影响[J]. 山东医药, 2025, 65(10): 117-122.
[31] Sauvage, F., Fraire, J.C., Remaut, K., Sebag, J., Peynshaert, K., Harrington, M., et al. (2019) Photoablation of Human Vitreous Opacities by Light-Induced Vapor Nanobubbles. ACS Nano, 13, 8401-8416. [Google Scholar] [CrossRef] [PubMed]
[32] Sauvage, F., Nguyen, V.P., Li, Y., Harizaj, A., Sebag, J., Roels, D., et al. (2022) Laser-Induced Nanobubbles Safely Ablate Vitreous Opacities in Vivo. Nature Nanotechnology, 17, 552-559. [Google Scholar] [CrossRef] [PubMed]
[33] Barras, A., Sauvage, F., de Hoon, I., Braeckmans, K., Hua, D., Buvat, G., et al. (2021) Carbon Quantum Dots as a Dual Platform for the Inhibition and Light-Based Destruction of Collagen Fibers: Implications for the Treatment of Eye Floaters. Nanoscale Horizons, 6, 449-461. [Google Scholar] [CrossRef] [PubMed]
[34] 秦玉成. 超声波治疗眼科玻璃体混浊的临床效果研究[J]. 中外医学研究, 2018, 16(13): 128-129.
[35] Lamy, R., Chan, E., Lee, O.T., et al. (2018) 880 kHz Ultrasound Treatment for Drug Delivery to the Vitreous Humor. American Journal of Translational Research, 10, 3162-3170.
[36] 刘登云. 超声波治疗玻璃体混浊的临床效果研究[J]. 中国农村卫生, 2020, 12(8): 11.
[37] 刘建爽, 边红霞. 玻璃体混浊治疗的临床进展[J]. 包头医学院学报, 2020, 36(1): 131-133.
[38] 王雪. 明目清浊汤治疗玻璃体浑浊的疗效分析[J]. 中国医药指南, 2017, 15(16): 201-202.
[39] 杨雅慧, 王伟志. 醒神开窍针刺法治疗飞蚊症28例[J]. 中国中医药科技, 2015, 22(6): 688.
[40] Shi, X., Liao, S., Mi, H., Guo, C., Qi, D., Li, F., et al. (2012) Hesperidin Prevents Retinal and Plasma Abnormalities in Streptozotocin-Induced Diabetic Rats. Molecules, 17, 12868-12881. [Google Scholar] [CrossRef] [PubMed]
[41] Mosca, M., Ambrosone, L., Semeraro, F., Casamassima, D., Vizzarri, F. and Costagliola, C. (2014) Ocular Tissues and Fluids Oxidative Stress in Hares Fed on Verbascoside Supplement. International Journal of Food Sciences and Nutrition, 65, 235-240. [Google Scholar] [CrossRef] [PubMed]
[42] Urios, P., Grigorova-Borsos, A. and Sternberg, M. (2007) Flavonoids Inhibit the Formation of the Cross-Linking AGE Pentosidine in Collagen Incubated with Glucose, According to Their Structure. European Journal of Nutrition, 46, 139-146. [Google Scholar] [CrossRef] [PubMed]
[43] Sulochana, K.N., Ramprasad, S., Coral, K., et al. (2003) Glycation and Glycoxidation Studies in Vitro on Isolated Human Vitreous Collagen. Medical Science Monitor, 9, BR220-4.
[44] Ankamah, E., Sebag, J., Ng, E. and Nolan, J.M. (2019) Vitreous Antioxidants, Degeneration, and Vitreo-Retinopathy: Exploring the Links. Antioxidants, 9, 7. [Google Scholar] [CrossRef] [PubMed]
[45] Shui, Y.B., Holekamp, N.M., Kramer, B.C., et al. (2009) The Gel State of the Vitreous and Ascorbate-Dependent Oxygen Consumption. Archives of Ophthalmology, 127, 475-482. [Google Scholar] [CrossRef] [PubMed]
[46] Kheirouri, S., Alizadeh, M. and Maleki, V. (2018) Zinc against Advanced Glycation End Products. Clinical and Experimental Pharmacology and Physiology, 45, 491-498. [Google Scholar] [CrossRef] [PubMed]